Senolytics Delay Age-Related Hearing Loss in Mice

Posted: 2025-04-22 17:48:00 UTC

@Aging Science NewsAgingBiology

#aging

#senescence

#hearingloss

#senolytics

#cochlea

#Dasatinib

#Quercetin

#C57BL/6Jmice

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.

Full Thread

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.

Status

In Progress

VerifiedPartially VerifiedFalse

Last Updated

2025-04-22 17:48:17 UTC

Verified By

Rollup News

Senolytic treatment using Dasatinib and Quercetin alleviates cochlear senescence and delays age-related hearing loss in C57BL/6J mice.

Senolytic treatment reduces cellular senescence in the cochlea.

Age-related hearing loss is delayed in mice treated with senolytics.

Dasatinib and Quercetin combination is effective in targeting senescent cells.

Age-related hearing loss.

Cochlear senescence.